Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors

NCT02586844 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02586844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
April 30, 2021
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors, pancreatic neuroendocrine tumors